Your search returned 43 results.

Results
	1.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	2.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	3.	GU and thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	4.	I-131 remnant ablation and adjuvant treatment: an interactive program MedStar authors: Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	5.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	6.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	7.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	8.	Current use and controversies for I-131 in thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2014 Citation: Unknown 2014 Jun 7 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	9.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	10.	I-131 dosimetry for differentiated thyroid cancer MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	11.	The draft 2015 ATA Guidelines on differentiated thyroid cancer: update and critical review MedStar authors: Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	12.	The utility of "blind" 131I treatments for differentiated thyroid cancer (DTC): an educational exhibit MedStar authors: Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Elboga U, Zeki C, Aktolun C, Van Nostrand D Local accession number: 2013_8 Add to cart (remove)
	13.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	14.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	15.	Correlating pre-therapy clinical evaluation and post-therapy response with patient-specific dosimetry in I-131 therapy of metastatic differentiated thyroid cancer. MedStar authors: Brown, Taneshea A Van Nostrand, Douglas Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Brown TA Byard J Hobbs R Plyku D Sgouros G Van Nostrand D. Wu D Local accession number: B2018454 Add to cart (remove)
	16.	Guidelines for the indications for 131I remnant ablation on differentiated thyroid cancer: a distillation and comparison of guidelines from seven organizations MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Guan H, Van Nostrand D, Li Y, Teng W, Khorjekar G Local accession number: 2013_7 Add to cart (remove)
	17.	Nationwide survey on the changes in release of I-131 therapy patients after the implementation of the 2011 NRC regulatory policy. MedStar authors: Burman, Kenneth D Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Bloom G Burman KD Van Nostrand D. Wartofsky L Wu D Local accession number: B2018640 Add to cart (remove)
	18.	Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L Local accession number: 2013_7 Add to cart (remove)
	19.	Checklist of criteria for the systematic assessment of patient-management guideline development. MedStar authors: Burman, Kenneth D Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_573 Add to cart (remove)
	20.	124I-NaI PET/CT based 3-D radiobiological Dosimetry (3D-RD) for 131I-NaI therapy of metastatic well-differentiated thyroid cancer. MedStar authors: Atkins, Frank Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Atkins F, Khorjekar G, Orquiza MD Local accession number: 2013_2 Add to cart (remove)
	21.	Alpharadinr in the treatment of skeletal metastasis secondary to metastatic prostate cancer: an educational exhibit MedStar authors: Duong, Eric Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Duong E, Khorjekar G, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	22.	Amifostine used clinically for salivary gland protection during therapy with radioiodine is cytotoxic for thyroid cancer cells MedStar authors: Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unpublished 2014 May 6 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Klubo-Gwiezdzinska J, Costello Jr J, Jensen K, Patel A, Van Nostrand D,Burman KD, Wartofsky L, Vasko V Local accession number: 2014.1_2 Add to cart (remove)
	23.	The diagnostic value of 124I PET compared to 131I imaging in differentiated thyroid cancer: systematic review and meta-analysis. MedStar authors: Burman, Kenneth D Heimlich, Layla Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Heimlich L Van Nostrand D. Wartofsky L Wu D Local accession number: B2018644 Add to cart (remove)
	24.	Enhancing techniques for radioiodine imaging of differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Van Nostrand, Douglas Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Gomes-Lima CJ Turner D Van Nostrand D. Wu D Local accession number: B2018647 Add to cart (remove)
	25.	Radioiodine refractory differentiated thyroid cancer classifications and evolution. MedStar authors: Gomes-Lima, Christiane J Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Gomes-Lima CJ Turner D Van Nostrand D Wu D Local accession number: A2017_574 Add to cart (remove)
	26.	Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_7 Add to cart (remove)
	27.	I-124 PET quantitation in the presence of I-131 background activity during I-131 therapy: a phantom study. MedStar authors: Atkins, Frank Brown, Taneshea A Moreau, Shari Van Nostrand, Douglas Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Atkins F Brown T Frey E Lodge M Moreau S Plyku D Van Nostrand D Wu D Local accession number: A2017_428 Add to cart (remove)
	28.	Sialoadenitis and xerostomia secondary to I-131 therapy in patients with differentiated thyroid cancer and who took sialagogues: a prospective study. MedStar authors: Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Orquiza M Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_576 Add to cart (remove)
	29.	Characterization of salivary gland side effects up to 7 days after 131I therapy: final report of the Thyroid Cancer Survivors" Association, Inc. (ThyCa) National Survey for Intermediate and Long Term Results. MedStar authors: Hall, Jordan Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza MH, Hall JP, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G Local accession number: 2013_2 Add to cart (remove)
	30.	Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors: Bikas, A Burman, Kenneth D Desale, Sameer Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unpublished 2015 Mar 5 Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Form of publication: Conference All authors: Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D Local accession number: 2014.1_1 Add to cart (remove)
	31.	Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer MedStar authors: Bikas, A Burman, Kenneth D Desale, Sameer Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K Local accession number: 2015_1 Add to cart (remove)
	32.	Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer MedStar authors: Bikas, A Burman, Kenneth D Desale, Sameer Mete, Mihriye Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K Local accession number: 2015_1 Add to cart (remove)
	33.	Poor compliance for continuous sialogogues in patient-reported surveys. MedStar authors: Burman, Kenneth D Kulkarni, Kanchan P Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Kharazi P Khorjekar G Kulkarni K Moreau S Van Nostrand D. Wartofsky L Wu D Local accession number: B2018646 Add to cart (remove)
	34.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)
	35.	Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Garcia, Carlos A Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Garcia C Kulkarni K Van Nostrand D. Wartofsky L Wu D Local accession number: B2018645 Add to cart (remove)
	36.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D Local accession number: 2013_2 Add to cart (remove)
	37.	Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_16 Add to cart (remove)
	38.	New use for an old isotope. MedStar authors: Burman, Kenneth D Gomes Lima, Christiane J Lee W Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Ylli, Dorina Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Lee W Burman K Gomes Lima CJ Van Nostrand D. Wartofsky L Wu D Ylli D Local accession number: B2018455 Add to cart (remove)
	39.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases. MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_2 Add to cart (remove)
	40.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_8 Add to cart (remove)
	41.	Overall survival rate of patients with differentiated thyroid cancer bone metastasis. MedStar authors: Burman, Kenneth D Gomes-Lima, Christiane J Kulkarni, Kanchan P Moreau, Shari Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Zeymo, Alexander Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Gomes Lima C Kulkarni K Moreau S Van Nostrand D Wartofsky L Wu D Zeymo A Local accession number: A2017_575 Add to cart (remove)
	42.	Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	43.	Radioiodine treatment of metastatic thyroid cancer: progression free survival is similar for patients with distant metastases prepared with recombinant human tsh or with thyroid hormone withdrawal. MedStar authors: Al-Jundi, Mohammad Burman, Kenneth D Chittimoju, Sanjita Gomes Lima, Christiane J Jat, Sunita Jhawar, Sakshi Pagadala, Prathyusha Van Nostrand, Douglas Wartofsky, Leonard Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Al-Jundi MN Burman KD Chittimoju S ENDO 2018, Gomes-Lima CJ Jat SK Jhawar S Jonklaas J Klubo-Gwiezdzinska J Mete M Pagadala P Van Nostrand D Wartofsky L Wehbeh L Zeymo A Local accession number: B2018452 Add to cart (remove)

Refine your search

Authors

Item types

Collections

Languages

Your search returned 43 results.